Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
AIDS ; 38(2): 267-269, 2024 02 01.
Article in English | MEDLINE | ID: mdl-38116724

ABSTRACT

Obesity incidence is increasing among people with HIV. Doravirine is a recommended first-line antiretroviral drug in many countries with no data from people with obesity. This study investigates the exposure of doravirine 100 mg standard dose in obese versus normal weight patients using clinical data combined with physiologically based pharmacokinetic modelling. Results from both approaches showed an elevated doravirine exposure during obesity, yet within the safety range of doravirine with no need for dose modification.


Subject(s)
Anti-HIV Agents , HIV Infections , HIV-1 , Humans , Anti-HIV Agents/therapeutic use , Reverse Transcriptase Inhibitors/therapeutic use , HIV Infections/complications , HIV Infections/drug therapy , Pyridones/therapeutic use
2.
Breastfeed Med ; 18(5): 356-361, 2023 05.
Article in English | MEDLINE | ID: mdl-37083439

ABSTRACT

Introduction: Guidelines in high-income countries recommend women living with human immunodeficiency virus (HIV) to formula feed their newborns, because the possibility of mother-to-child-transmission of HIV during breastfeeding cannot be ruled out. It is an ongoing debate if the possible transmission risk outweighs the medical, cultural, psychological, and social importance of breastfeeding in women stable on current first-line suppressive antiretroviral regimens. The study aim was to explore breastfeeding desires and decision-making of immigrant and nonimmigrant women living with HIV in the Netherlands. Method: A questionnaire was administered orally or online to 82 women living with HIV in the Netherlands. The breastfeeding desires of the participants were collected as categorical data, and breastfeeding decision-making and willingness to adhere to additional monitoring were collected on a 5-point Likert scale. Categorical data were presented as proportions, and Likert scale data were presented in Likert scale bar plots. Results: Seventy-one percent of the participants expressed a desire to breastfeed in the future. The most important factors influencing decision-making to breastfeed were the chance of transmission of HIV to the infant and the advice by the doctor or nurse practitioner. Of the participants, 42% expressed their interest in breastfeeding with a <1/100 transmission risk. More than half of the participants expressed their interest to breastfeed with additional monitoring. Conclusions: A substantial proportion of the women living with HIV in the Netherlands has a desire to breastfeed, of which the majority are willing to adhere to additional monitoring to do so.


Subject(s)
Breast Feeding , HIV Infections , Infant , Pregnancy , Female , Infant, Newborn , Humans , HIV Infections/drug therapy , HIV , Developed Countries , Netherlands/epidemiology , Infectious Disease Transmission, Vertical/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...